Aroa Biosurgery shares have surged on the back of full-year results that exceeded guidance and restored the company to profitability. ... Read More The post Health Check: Aroa’s ‘hero’ product propels ...

Aroa surges to profitability in FY25 with a NZ$4.2 million normalised EBITDA profit Reports total revenue for full year of NZ$84.7 million, up 23% and exceeding guidance Provides total revenue ...

Stockhead’s health and biotech expert Tim Boreham is back in the studio for another instalment of the Health Kick Podcast.

Revenue: NZ$84.7m (up 23% from FY 2024). Net loss: NZ$3.81m (loss narrowed by 64% from FY 2024). NZ$0.011 loss per share (improved from NZ$0.031 loss in FY 2024). Revenue exceeded analyst ...

AUCKLAND, New Zealand, May 1, 2025 /PRNewswire/ -- Soft tissue regeneration company, Aroa Biosurgery, is pleased to announce a milestone in clinical evidence. There are now over 100 peer-reviewed ...

Aroa was up about 7% earlier on Tuesday, after recording its second consecutive quarter of positive cash flows from operations and reconfirming full-year FY25 guidance. AROA lifts after recording ...

Aroa Biosurgery shares have surged on the back of full-year results that exceeded guidance and restored the company to profitability. Aroa’s revenue came in at NZ$84.7 million for the year to ...

New-Zealand-based soft-tissue repair company Aroa Biosurgery is looking in good shape after delivering its first full-year profit since listing on the ASX in 2020. Aroa surges to profitability in ...